Horizon 2020. Bioconversion of non-agricultural

Author: Nikola Benin

h2020_globe_small

OBJECTIVES OF THE FUNDING PROGRAM Biotechnology has achieved spectacular progress as an enabling technology to drive long term sustainability and growth across various economic sectors, in particular in the health, pharmaceutical and chemical industries, and in plant breeding. The overall “Leitmotiv” for the activities included in this area is to facilitate cross-sectoral transfer of know-how and exploiting relevant synergies (e.g. regarding process technologies or advanced materials) to create added value for Europe through convergence of approaches.Topics opened in this call: Topic:  Bioconversion of non-agricultural waste into biomolecules for industrial applications  H2020-NMBP-2016-2017

Topic Description

Specific Challenge:

Following the principle of a circular economy, industrial by-products and waste from non-agricultural sectors, could be considered feed stock for bio-conversion into value-added industrial products.

However, most of these bio-waste fractions are used nowadays for low-value applications only, such as for energy generation in incineration facilities, as fodder in livestock industries and as fertilisers in agriculture. Therefore, responding to the need to improve industrial resource efficiency, the current main challenges are to identify economically viable links between waste generation and waste utilization, and to develop the necessary technologies (including biotechnologies) for bioconversion of waste into higher added-value products.

Topic conditions and documents

Please read carefully all provisions below before the preparation of your application.

  1. LIST OF COUNTRIES and APPLICABLE RULES FOR FUNDING
    described in part A of the General Annexes of the General Work Programme.

    Note also that a number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon 2020 projects (follow the links to Australia, Brazil, Canada, China, Hong Kong &Macau, India, Japan, Republic of Korea, Mexico, Russia, Taiwan).

  2. ELIGIBILITY and ADMISSIBILITY CONDITIONS
    described in part B and C of the General Annexes of the General Work Programme.

Link: https://ec.europa.eu/research/participants/portal/desktop/en/opportunities/h2020/topics/biotec-02-2016.html

Leave a comment